Today: 20 May 2026
3i Group share price slips early as BoE decision looms and Action seminar nears
3 February 2026
1 min read

3i Group share price slips early as BoE decision looms and Action seminar nears

London, Feb 3, 2026, 08:30 GMT — Regular session.

3i Group shares slipped 0.2% to 3,326.5 pence in early Tuesday trading, bouncing between 3,310 and 3,358 pence. The stock dipped below Monday’s close of 3,333 pence and has been moving within a 52-week range of 2,957 to 4,497 pence.

Why it matters now: Investors are gearing up for Thursday’s Bank of England announcement, with most economists surveyed by Reuters expecting the Bank Rate to hold steady at 3.75%. “This week we could, for once, have a boring Bank of England meeting,” noted Mohamad Al-Saraf, an FX and fixed income associate at Danske Bank. Reuters

For 3i, the policy decision is key because rate expectations influence how investors value unlisted assets and their cashflows. The FTSE 100 has helped, hitting a record close on Monday. Investors shifted into banks and defensive stocks, even as commodity-linked shares dropped. Ipek Ozkardeskaya from Swissquote Bank noted the record close signals better risk appetite despite the broader commodity selloff.

That calm barely held. After steep swings in metals and the dollar following Donald Trump’s pick of Kevin Warsh to head the Federal Reserve, global trade steadied on Tuesday. The volatility pushed some leveraged players out. “It will take a long time for them to rebuild a bull or bear position… so they are staying away from the market,” said Steven Leung of UOB Kay Hian. Reuters

3i Group, a London-listed investment firm, specializes in private equity and infrastructure. It supports mid-market buyouts and growth capital, as well as infrastructure projects.

With much of its portfolio unlisted, investors focus heavily on net asset value (NAV)—the value of assets minus liabilities—and whether the shares trade above or below that benchmark. According to Hargreaves Lansdown, 3i’s estimated NAV stands at 3,023 pence per share, suggesting the stock is trading at roughly a 10.9% premium.

The central bank’s next move is set for Feb. 5, with the Bank releasing the MPC summary, minutes, and the February Monetary Policy Report.

Beyond interest rates, investors have their sights set on 3i’s Action Capital Markets Seminar scheduled for March 26. The firm says this will be a webcast event. Market watchers will be keen for new insights on the retailer and its impact on portfolio returns.

Still, the situation works both ways. Should yields spike once more or consumer demand weaken, the market might reassess private asset values sharply, tightening any premium to NAV.

Stock Market Today

  • Williams-Sonoma Gains 1.58% as Market Declines, Eyes Upcoming Earnings
    May 19, 2026, 7:31 PM EDT. Williams-Sonoma (WSM) shares rose 1.58% to $171.83, outperforming the S&P 500's 0.67% drop. The stock had declined 16.27% over the past month, lagging the sector's 0.69% loss but behind the S&P 500's 4% gain. Investors await WSM's upcoming earnings report, expected to show $1.80 per share in EPS, down 2.7% year-over-year, with revenue projected to rise 4.25% to $1.8 billion. The company's full-year estimates anticipate 4.75% EPS growth and 4.39% revenue growth. Analyst estimate revisions have nudged EPS projections higher by 0.58% in 30 days, with WSM holding a Zacks Rank #3 (Hold). Valuation indicators show a Forward P/E of 18.27, slightly below industry average, while the PEG ratio of 2.12 exceeds the Retail - Home Furnishings sector average of 1.63.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
Northern Star share price rebounds after gold shock; NST’s Feb. 12 results loom
Previous Story

Northern Star share price rebounds after gold shock; NST’s Feb. 12 results loom

Venezuela oil exports jump, but Exxon Mobil and Chevron still won’t bet big
Next Story

Venezuela oil exports jump, but Exxon Mobil and Chevron still won’t bet big

Go toTop